Survival by sidedness of metastatic colorectal cancer (mCRC) treated with epidermal growth factor receptor antibodies (EGFR-Ab) in the refractory setting: A population-based study of 1509 patients

Eva Segelov, Craig Earle, Alan Venook, R Saskin, Layla Mofid, Simron Singh

Research output: Contribution to conferenceAbstract

Original languageEnglish
Number of pages1
Publication statusPublished - 2018

Cite this